The global Fertility Test Market is expanding as awareness of reproductive health increases and consumers seek convenient, accessible, and personalized fertility monitoring solutions.
According to Fortune Business Insights, the global fertility test market was valued at USD 8.14 billion in 2025 and is projected to grow from USD 8.80 billion in 2026 to USD 16.53 billion by 2034, exhibiting a CAGR of 8.19% during 2026–2034.
Increasing awareness regarding infertility and reproductive health is one of the key factors driving the fertility test market. Delayed parenthood, changing lifestyles, stress, obesity, environmental factors, and increasing age at first pregnancy are encouraging more individuals to seek early fertility assessments.
Consumers are increasingly using ovulation prediction kits, hormone testing devices, and male fertility tests to understand reproductive health and support conception planning. Fertility clinics and healthcare providers are also emphasizing preventive reproductive care and personalized diagnostic strategies.
Digital technologies are significantly changing how consumers monitor fertility. Smartphone-connected fertility tracking devices, app-based ovulation monitoring, wearable health technologies, and AI-powered platforms are becoming increasingly popular.
These technologies can combine cycle information, hormone measurements, and other health data to provide personalized reproductive insights. Manufacturers are also developing home-based testing solutions that allow consumers to monitor fertility conveniently and privately.
By test type, ovulation prediction tests account for 48% of the global fertility test market, making them the leading segment. Their popularity is supported by consumer demand for convenient and affordable home-based fertility monitoring.
Female fertility hormone tests account for 34% of the market and are used to evaluate reproductive hormones associated with ovulation, ovarian reserve, and fertility treatment planning.
For detailed market insights, visit: https://www.fortunebusinessinsights.com/fertility-test-market-117187
Male fertility tests account for 18% of the market. Growing recognition of male infertility is increasing demand for home-based semen analysis and hormone testing solutions.
By application, female applications account for 72% of the global fertility test market, supported by widespread use of ovulation tracking, hormone monitoring, menstrual cycle management, and fertility planning.
Male applications represent 28% of the market. Rising awareness of male reproductive health and greater acceptance of comprehensive fertility assessments are supporting demand for semen analysis and hormone testing technologies.
By sample type, urine-based testing accounts for approximately 68% of the market. Urine tests are widely used in home-based fertility diagnostics because they are non-invasive, affordable, easy to administer, and capable of delivering rapid results.
The blood-based segment holds nearly 32% of the market. Blood testing is commonly used for detailed hormone analysis, including measurements that support fertility evaluation and treatment planning in clinical environments.